ORPHAN DRUGS FOR RARE DISEASES IN THE EUROPEAN UNION: BRIDGING THE GAP BETWEEN DRUG DEVELOPMENT AND UNMET MEDICAL NEEDS?
Por:
Catala-Lopez, F, Peiro, S, Genova-Maleras, R, Garcia-Altes, A, Sanfelix-Gimeno, G, Alvarez-Martin, E, Morant-Ginestar, C and Ridao, M
Publicada:
1 nov 2011
Resumen:
Filiaciones:
:
Ctr Super Invest Salud Publ CSISP, Valencia, Spain
:
Ctr Super Invest Salud Publ CSISP, Valencia, Spain
Genova-Maleras, R:
Reg Hlth Council, Primary Care Gen Directorate, Madrid, Spain
Garcia-Altes, A:
Catalan Agcy Hlth Informat Assessment & Qual CAHI, Barcelona, Spain
:
Ctr Super Invest Salud Publ CSISP, Valencia, Spain
Alvarez-Martin, E:
Rey Juan Carlos Univ, Madrid, Spain
:
Ctr Super Invest Salud Publ CSISP, Valencia, Spain
Inst Aragones Ciencias Salud I CS, Zaragoza, Spain
Bronze
|